Showing results 24 to 38 of 38
< previous
| Preview | Issue Date | Title | Author(s) |
| 1999 | Letter to the Editor: 1H and 15N chemical shift assignments for domain 4 of the common β-chain of the IL-3, IL-5 and GM-CSF receptors | Mulhern, T.; Bagley, C.; Gaunt, C.; Lopez, A.; Vadas, M.; D'Andrea, R.; Booker, G. |
| 2013 | Low GFI1 expression in white blood cells of CP-CML patients at diagnosis is strongly associated with subsequent blastic transformation | Kok, C.; Watkins, D.; Leclercq, T.; D'Andrea, R.; Hughes, T.; White, D. |
| 2011 | Mechanisms of Co-operation of DNMT3A Mutations with JAK2 V617F Through Histone H4 Arginine 3 Provides New Insights in MPN Disease Pathogenesis | Rao, N.; Butcher, C.; Neufing, P.; Bray, S.; Hahn, C.; Scott, H.; Vaz de Melo, J.; Ross, D.; Lewis, I.; Bardy, P.; D'Andrea, R.; Annual Meeting and Exposition of the American Society of Hematology (53rd : 2011 : San Diego, California) |
| 2017 | miR-155 as a potential target of IL-3 signaling in primary AML cells | Sadras, T.; Kok, C.; Perugini, M.; Ramshaw, H.; D'Andrea, R. |
| 2000 | Molecular aspects of polycythemia vera (review) | Butcher, C.; D'Andrea, R. |
| 2001 | Molecular cloning of a human Vent-like homeobox gene | Moretti, P.; Davidson, A.; Baker, E.; Lilley, B.; Zon, L.; D'Andrea, R. |
| 2013 | NPM1 mutations occur rarely or not at all in chronic myeloid leukaemia patients in chronic phase or blast crisis | Watkins, D.; Hughes, T.; White, D.; D'Andrea, R. |
| 2014 | Nutlin-3a efficacy in sarcoma predicted by transcriptomic and epigenetic profiling | Pishas, K.; Neuhaus, S.; Clayer, M.; Schreiber, A.; Lawrence, D.; Perugini, M.; Whitfield, R.; Farshid, G.; Manavis, J.; Chryssidis, S.; Mayo, B.; Haycox, R.; Ho, K.; Brown, M.; D'Andrea, R.; Evdokiou, A.; Thomas, D.; Desai, J.; Callen, D.; Neilsen, P. |
| 1997 | Roles of the N and C terminal domains of the interleukin-3 receptor alpha chain in receptor function. | Barry, S.; Korpelainen, E.; Sun, Q.; Stomski, F.; Moretti, P.; Wakao, H.; D'Andrea, R.; Vadas, M.; Lopez, A.; Goodall, G. |
| 2013 | Signalling by the βc family of cytokines | Hercus, T.; Dhagat, U.; Kan, W.; Broughton, S.; Nero, T.; Perugini, M.; Sandow, J.; D'Andrea, R.; Ekert, P.; Hughes, T.; Parker, M.; Lopez, A. |
| 1999 | Simultaneous antagonism of interleukin-5, granulocyte-macrophage colony-stimulting factor, and interleukin-3 stimulation of human eosinophils by targetting the common cytokine binding site of their receptors | Sun, Q.; Jones, K.; McClure, B.; Cambareri, B.; Zacharakis, B.; Iversen, P.; Stomski, F.; Woodcock, J.; Bagley, C.; D'Andrea, R.; Lopez, A. |
| 2002 | Sphingosine kinase interacts with TRAF2 and dissects tumor necrosis factor-a signaling | Xia, P.; Wang, L.; Moretti, P.; Albanese, N.; Chai, F.; Pitson, S.; D'Andrea, R.; Gamble, J.; Vadas, M. |
| 2017 | Targeting sphingosine kinase 1 induces MCL1-dependent cell death in acute myeloid leukemia. | Powell, J.; Lewis, A.; Zhu, W.; Toubia, J.; Pitman, M.; Wallington-Beddoe, C.; Moretti, P.; Iarossi, D.; Samaraweera, S.; Cummings, N.; Ramshaw, H.; Thomas, D.; Wei, A.; Lopez, A.; D'Andrea, R.; Lewis, I.; Pitson, S. |
| 2002 | The nucleotide-binding site of human sphingosine kinase 1 | Pitson, S.; Moretti, P.; Zebol, J.; Zareie, R.; Derian, C.; Darrow, A.; Qi, J.; D'Andrea, R.; Bagley, C.; Vadas, M.; Wattenberg, B. |
| 2013 | The preferential occurrence of FLT3-TKD mutations in inv(16) AML and impact on survival outcome: A combined analysis of 1053 core-binding factor AML patients | Kok, C.; Brown, A.; Perugini, M.; Iarossi, D.; Lewis, I.; D'Andrea, R. |
